• JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms 

      Rao, Tata Nageswara; Hansen, Nils; Hilfiker, Julian; Rai, Shivam; Majewska, Julia-Magdalena; Leković, Danijela; Gezer, Deniz; Andina, Nicola; Galli, Serena; Cassel, Teresa; Geier, Florian; Delezie, Julien; Nienhold, Ronny; Hao-Shen, Hui; Beisel, Christian; Di Palma, Serena; Dimeloe, Sarah; Trebicka, Jonel; Wolf, Dominik; Gassmann, Max; Fan, Teresa W. -M.; Lane, Andrew N.; Handschin, Christoph; Dirnhofer, Stefan; Kroeger, Nicolaus; Hess, Christoph; Radimerski, Thomas; Koschmieder, Steffen; Čokić, Vladan; Skoda, Radek C. (Amer Soc Hematology, Washington, 2019)